firming shampoo

1. INCI & CAS

INCI: Palmitoyl Tripeptide-1 · CAS: 147732-56-7

2. Role in the formula

Palmitoyl tripeptide-1 is a cosmetic lipopeptide. The guide uses a low ppm-to-0.05% framing and does not claim a clinical lift.

3. Typical use levels (formulation guide)

• For serums and eye creams, the recorded level is about 2–10 ppm of pure peptide, or as the supplier blend states for the formula.

Follow the supplier blend TDS. Many trade blends are already diluted.

4. Regulatory sources & global compliance

• CosIng may identify Palmitoyl Tripeptide-1 as an ingredient, but its entry does not approve a material grade or finished formula.
• Before EU placement, Regulation (EC) No 1223/2009 requires the finished product's safety, including the formula in which Palmitoyl Tripeptide-1 is used, to be assessed for the completed formula, not simply for an ingredient in isolation.
• Use current supplier documentation for the purchased Palmitoyl Tripeptide-1 grade and verify applicable destination-market filings.

5. Safety & risk assessment

Use the stated level as reference guidance for cosmetic formulation; it is not evidence of drug approval or OTC authorization and the final formula should undergo patch and stability assessment.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; for oxidation-sensitive formulas, consider an airless or pump pack; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• The cosmetic role of Palmitoyl Tripeptide-1 is presented as peptide firming.

• This formulation entry cannot verify therapeutic effects, curative outcomes, or unsupported certification statements.
• The Palmitoyl Tripeptide-1 entry should not be cited in support of whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Bakuchiol · CAS: 10309-37-2

2. Role in the formula

Bakuchiol is a meroterpene phenol used around 0.5–1% in cosmetic leave-ons. Do not call it vitamin A or a drug retinoid.

3. Typical use levels (formulation guide)

• For serums and creams, the recorded level is 0.5–1% for the formula.

Oil-soluble. Add in cool-down and protect from light.

4. Regulatory sources & global compliance

• The CosIng record for Bakuchiol, where listed, is informational rather than product-specific authorization.
• The framework in Regulation (EC) No 1223/2009 requires the final cosmetic with Bakuchiol to undergo a safety assessment as a finished-product assessment.
• Check the supplier's technical information for the Bakuchiol grade and confirm the relevant market filing list.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; it does not establish drug approval or OTC-monograph status with patch response and finished-product stability still to be verified.

6. Stability & packaging

Use cool, sealed storage away from strong light for the bulk; choose a package with oxidation sensitivity in view; confirm compatibility and stability using the selected formula and pack.

7. Claims language (Do / Don’t)

• The cosmetic concept for Bakuchiol in this entry centers on bakuchiol.

• The ingredient guidance is not evidence of claims of drug action or cure, or a product certification outside the supporting records.
• The information about Bakuchiol cannot verify a whitening result, acne-treatment effect, antiperspirant use, sunscreen performance, or hair growth.

1. INCI & CAS

INCI: Decyl Glucoside · CAS: 68515-73-1

2. Role in the formula

Decyl glucoside supplies the mild nonionic-surfactant role in a sulfate-free primary cleansing system.

3. Typical use levels (formulation guide)

• Use 4–10% active for washes as a reference, and confirm the supplied activity.

Route Decyl Glucoside through the water phase.

4. Regulatory sources & global compliance

• A CosIng listing for Decyl Glucoside provides ingredient information, not approval of a supplied grade or finished product.
• Regulation (EC) No 1223/2009 sets the requirement for an assessment addressing the safety of the finished product that contains Decyl Glucoside before the finished product is marketed.
• Establish grade-specific details for Decyl Glucoside from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; it should not be read as a drug authorization or OTC listing and patch and stability testing remain part of finished-product review.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; where oxidation is a concern, evaluate airless or pump packaging; test the selected package with the confirmed batch for stability and fit.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Decyl Glucoside emphasizes a sugar-based surfactant role.

• The development record cannot substantiate drug effects, clinical cures, or unsupported product certifications.
• The Decyl Glucoside entry should not be cited in support of a skin-lightening result, acne treatment, antiperspirant action, sunscreen efficacy, or hair growth.